ICoLA 2021

Date	Time	Room	Session/Title	Presentation Time	Presentation Title	Role
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson

BREAKFAST SYMPOSIUM 4 [Yooyoung]: Sep.11(Sat.)
08:00 - 09:00; Room 1

Chairperson In-Kyung Jeong (Kyung Hee University, Korea)

Panels Heung Yong Jin (Jeonbuk National University, Korea), Inchang Hwang (Seoul National University, Korea)

08:00-08:20	Interim analysis of APOLLO Study: 2 years follow-up results Seung-Woon Rha (Korea University, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 5 [Chong Kun Dang]: Sep.11(Sat.)
08:00 - 09:00; Room 2

Chairperson Moon-Kyu Lee (Eulji University, Korea)

Panels Jun-Sung Moon (Yeungnam University, Korea), Sung-Eun Kim (Hallym University, Korea)

08:00-08:20	How to manage vascular health with statin in Korean patient: evidence based medicine LIPILOU Jong-Young Lee (Sungkyunkwan University, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 6 [Celltrion/Jeil Pharmaceutical]: Sep.11(Sat.)
08:00 - 09:00; Room 3

Chairperson Eun-Jung Rhee (Sunkyunkwan University, Korea)

Panels Hyun Min Kim (Chung-Ang University, Korea), Ji Yong Jang (NHIS Ilsan Hospital, Korea)

08:00-08:20	CV safety of Alogliptin in T2DM patients Jae Hyoung Park (Korea University, Korea)
08:20-08:30	Discussion

PLENARY LECTURE 4: Sep.11(Sat.)
09:00 - 09:30; Room 1+2+3

Chairperson Joong-Yeol Park (University of Ulsan, Korea)

Hypertriglyceridemia: diagnostic and therapeutic implications Alan Remaley (National Institutes of Health, USA)

BREAK: Sep.11(Sat.)
09:30 - 09:40; All

SYMPOSIUM 14 Recent studies on PCSK9 inhibitors & omega-3 PUFA: Sep.11(Sat.)
09:40 - 11:20; Room 1

Chairpersons Jaetaek Kim (Chung-Ang University, Korea), Hyun Jae Kang (Seoul National University, Korea)

Panels Eun-Jung Rhee (Sunkyunkwan University, Korea), Su Yeon Choi (Seoul National University, Korea)

09:40-10:05	Latest data on siRNA against PCSK9 Masatsune Ogura (Chiba University Graduate School of Medicine, Japan)
10:05-10:30	Patient selection for PCSK9 MAb based therapies Kausik Ray (Imperial College London, UK)
10:30-10:55	Biological effect & clinical benefit of omega-3 PUFA Mi Kyung Kim (Inje University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 15 New treatment agents for dyslipidemia: Sep.11(Sat.)
09:40 - 11:20; Room 2

Chairpersons Dae Jung Kim (Ajou University, Korea), Byung Jin Kim (Sungkyunkwan University, Korea)

Panels Hyun Min Kim (Chung-Ang University, Korea), Byeong-Keuk Kim (Yonsei University, Korea)

09:40-10:05	The metabolic effects of antisense oligonucleotides treatments in dyslipidemia Gissette Reyes-Soffer (Columbia University, USA)
10:05-10:30	Emerging targets for management of dyslipidemia Hun-Jun Park (The Catholic University of Korea, Korea)
10:30-10:55	New PPARalpha agonist Sang Yong Kim (Chosun University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 16 Update on lipoprotein metabolism & regulation: Sep.11(Sat.)
09:40 - 11:20; Room 3

Chairpersons Ki Hoon Han (University of Ulsan, Korea) , In-Kyung Jeong (Kyung Hee University, Korea)

Panels Byung Wan Lee (Yonsei University, Korea), Gyuri Kim (Sunkyunkwan University, Korea)

09:40-10:05	Apolipoprotein C3 as a regulator of triglyceride-rich lipoproteins in diabetes and its complications Jenny E. Kanter (University of Washington, USA)
10:05-10:30	What's new in intracellular lipid trafficking Young Mi Park (Ewha Womans University, Korea)
10:30-10:55	Regulation of microsomal triglyceride transfer protein (MTP) in lipid metabolism Mahmood Hussain (New York University, USA)
10:55-11:20	Discussion

SYMPOSIUM 17 What’s new in lifestyle/nutrition modification: Sep.11(Sat.)
09:40 - 11:20; Room 4

Chairpersons Yangha Kim (Ewha Womans University, Korea), Eung-Ju Kim (Korea University, Korea)

Panels Hannah Oh (Korea University, Korea), Jung Hwan Park (Hanyang University, Korea), Hyunjung Lim (Kyung Hee University, Korea)

09:40-10:05	Vitamin D in cardiometabolic disease - the more the better? Yongjoo Park (Chonnam National University, Korea)
10:05-10:30	Systems science in biomedical research regarding obesity and noncommunicable chronic diseases Hong Xue (George Mason University, USA)
10:30-10:55	Nutrition policies to improve diet and reduce health and economic burdens of cardiometabolic diseases: a microsimulation study Yujin Lee (Myongji University, Korea)
10:55-11:20	Discussion

SYMPOSIUM 18 (Joint with JAS) Update on platelet in atherosclerosis & acute coronary syndrome: Sep.11(Sat.)
09:40 - 11:20; Room 5

Chairpersons Young-Bae Park (Seoul National University, Korea), Youngkeun Ahn (Chonnam National University, Korea)

Panels Hyun Kuk Kim (Chosun University, Korea), Chul-Ung Choi (Korea University, Korea)

09:40-10:05	Update on pathophysiology of acute coronary syndrome Hiroyuki Hao (Nihon University, Japan)
10:05-10:30	Topics in the antiplatelet therapy: Daily dose of thienopyridine ADP receptor antagonists in Japan and the effect of thrombocytopenia on the DAPT therapy Hisanori Horiuchi (Tohoku University, Japan)
10:30-10:55	Latest therapeutic strategies to modify platelet function Soon Jun Hong (Korea University, Korea)
10:55-11:20	Discussion

COFFEE BREAK: Sep.11(Sat.)
11:20 - 11:40; All

PLENARY LECTURE 5: Sep.11(Sat.)
11:40 - 12:10; Room 1+2+3

Chairperson Sang Hong Baek (The Catholic University of Korea, Korea)

Genetics/epigenetic approach in studies of lipid metabolism & atherosclerosis Kiran Musunuru (University of Pennsylvania, USA)

LUNCHEON SYMPOSIUM 5 [Daewoong]: Sep.11(Sat.)
12:10 - 13:10; Room 1

Chairperson Sang Hong Baek (The Catholic University of Korea, Korea)

Panels Jung Hwan Park (Hanyang University, Korea), Eun Sun Jin (Kyung Hee University, Korea)

12:10-12:30	Lower is better & combination is better [Ezetimibe+Rosuvastatin] Soo Heon Kwak (Seoul National University, Korea)
12:30-12:40	Discussion

LUNCHEON SYMPOSIUM 6 [JW Pharmaceutical]: Sep.11(Sat.)
12:10 - 13:10; Room 2

Chairperson Hyun Chul Lee (Yonsei University, Korea)

Panels Sunghwan Suh (Dong-A University, Korea), Young Jin Youn (Yonsei University, Korea)

12:10-12:30	Cutting edge care of Pitavastatin with Ezetimibe combination therapy Ki Hoon Han (University of Ulsan, Korea)
12:30-12:40	DIscussion

LUNCHEON SYMPOSIUM 7 [Hanmi]: Sep.11(Sat.)
12:10 - 13:10; Room 3

Chairperson Jeong Euy Park (Sungkyunkwan University, Korea)

Panels Sang Yong Kim (Chosun University, Korea), Jong shin Woo (Kyung Hee University, Korea)

12:10-12:30	Why should we consider Rosuvastatin + Ezetimibe fixed dose combination? Jung-Kyu Han (Seoul National University, Korea)
12:30-12:40	Discussion

LUNCHEON SYMPOSIUM 8 [HK. inno.N]: Sep.11(Sat.)
12:10 - 13:10; Room 4

Chairperson Jeong Taek Woo (Kyung Hee University, Korea)

Panels So Hun Kim (Inha University, Korea), Jong-Chan Youn (The Catholic University of Korea, Korea)

12:10-12:30	Controlling dyslipidemia and CV risk with Atorvastatin and Ezetimibe Soon Jun Hong (Korea University, Korea)
12:30-12:40	Discussion

ORAL PRESENTATION 3: Sep.11(Sat.)
13:10 - 14:10; Room 1

Chairperson Eun Seok Kang (Yonsei University, Korea), Soon Jun Hong (Korea University, Korea)

Panels Sungsoo Cho (Dankook University, Korea), Seung-Jun Lee (Yonsei University, Korea), Hyun Duk Jang (Seoul National University, Korea)

13:10-13:17	Treatment of enolase-1 antagonist peptide prevents atherosclerosis in LDLR KO mice Vo Hoang Nguyet Dan (Soonchunhyang University, Korea)
13:17-13:24	The potential of macrophage-specific soluble Ninj1 as a therapeutic target in atherosclerosis Sejin Jeon (Andong National University, Korea)
13:24-13:31	Loss of the mixed lineage kinase domain-like protein decreases necrotic core but increases macrophage lipid accumulation in atherosclerosis Adil Rasheed (University of Ottawa Heart Institute, Canada)
13:31-13:38	Endothelial OASL1 deficiency promotes endothelial dysfunction and atherosclerotic plaque formation TaeKyeong Kim (Ewha Womans University, Korea)
13:38-13:45	Macrophage-specific PCSK9 promotes Inflammatory activation after acute myocardial infarction Shin Hye Moon (Ewha Womans University, Korea)
13:45-14:10	Q&A

ORAL PRESENTATION 4: Sep.11(Sat.)
13:10 - 14:10; Room 3

Chairperson Jung-Sun Kim (Yonsei University, Korea, Ung Kim (Yeungnam University, Korea)

Panels Ji-won Hwang (Inje University, Korea), So Hun Kim (Inha University, Korea)

13:10-13:17	Intravital two-photon imaging of dynamics of hepatic lipid droplets in fasted and refed state Jieun Moon (Korea Advanced Institute of Science and Technology, Korea)
13:17-13:24	Relative contributions of statin intensity, achieved LDL-C level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes Ji Yoon Kim (Korea University, Korea)
13:24-13:31	Hypertriglyceridemia is an independent risk factor for cardiovascular diseases in Korean adults aged 30-49 years: a nationwide population-based study Bo Kyung Koo (Seoul National University, Korea)
13:31-13:38	Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose Chan Joo Lee (Yonsei University, Korea)
13:38-13:45	Association between dietary acid load and metabolic syndrome risk ? Mi Ri Ha (Dong-A University, Korea)
13:45-14:10	Q&A

PLENARY LECTURE 6: Sep.11(Sat.)
14:10 - 14:40; Room 1+2+3

Chairperson Hyo-Soo Kim (Seoul National University, Korea)

Targeting smooth muscle cell in management of atherosclerotic cardiovascular disease Martin Bennett (University of Cambridge, UK)

COFFEE BREAK: Sep.11(Sat.)
14:40 - 15:00; All

SYMPOSIUM 19 Targeting Lp(a) & inflammation in ASCVD: Sep.11(Sat.)
15:00 - 16:40; Room 1

Chairpersons Seok Won Park (Yonsei University, Korea), Seung Hwan Han (Gachon Universtiy, Korea)

Panels Young Sup Byun (Inje University, Korea), Kyung-Soo Kim (CHA University, Korea)

15:00-15:25	Lp(a) as a risk factor Hiroshi Yoshida (Jikei University School of Medicine, Japan)
15:25-15:50	Recent results on Lp(a) therapeutics Sotirios Tsimikas (University of California San Diego, USA)
15:50-16:15	Anti-inflammatory treatment to reduce CV risk Jung Ho Heo (Kosin University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 20 Current & future treatment for HeFH & HoFH: Sep.11(Sat.)
15:00 - 16:40; Room 2

Chairpersons Jeong Taek Woo (Kyung Hee University, Korea), Sung Hee Choi (Seoul National University, Korea)

Panels Jae Hyoung Park (Korea University, Korea), Masahiro Koseki (Osaka University, Japan), Hyung Joon Joo (Korea University, Korea)

15:00-15:25	Personalized medicine for patients with FH Hayato Tada (Kanazawa University, Japan)
15:25-15:50	Current trend in treatment of HeFH/HoFH Dirk Blom (Hatter Institute for Cardiovascular Research in Africa, South Africa)
15:50-16:15	Upcoming treatment agents for FH Sang-Hyun Kim (Seoul National University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 21 HDL update: Sep.11(Sat.)
15:00 - 16:40; Room 3

Chairpersons Ji Dong Sung (Sungkyunkwan University, Korea), Sang-Hak Lee (Yonsei University, Korea)

Panels Sang-Ho Jo (Hallym University, Korea), Jang-Whan Bae (Chungbuk National University, Korea)

15:00-15:25	Beyond HDL-cholesterol: the search for functional biomarkers of HDL Arnold von Eckardstein (University of Zürich, Switzerland)
15:25-15:50	HDL and the cardiovascular risk in diabetes Tomas Vaisar (University of Washington, USA)
15:50-16:15	What’s new in HDL-modifying therapeutics? Jang Hoon Lee (Kyungpook National University, Korea)
16:15-16:40	Discussion

SYMPOSIUM 22 Role of noncoding RNA in lipid metabolism & vascular disease: Sep.11(Sat.)
15:00 - 16:40; Room 4

Chairpersons Youngmi Kim (Kyung Hee University, Korea), Sungha Park (Yonsei University, Korea)

Panels Hyun Kook (Chonnam National University, Korea), Hae-Young Lee (Seoul National University, Korea)

15:00-15:25	Function of miR-33a/b in lipid and systemic metabolism Koh Ono (Kyoto University, Japan)
15:25-15:50	Non-coding RNA control of cholesterol metabolism and atherosclerosis Katey Rayner (University of Ottawa, Canada)
15:50-16:15	The role of non-coding RNAs in vascular smooth muscle cells Young-Kook Kim (Chonnam National University, Korea)
16:15-16:40	Discussion

PUBLICATION COMMITTEE SESSION: Sep.11(Sat.)
15:00 - 16:40; Room 5

Chairpersons Jaetaek Kim (Chung-Ang University, Korea), Jeong-Min Kim (Seoul National University, Korea)

15:00 - 15:20	REvisiting lipids in REtinal diseases : a focused review on age-related macular degeneration and diabetic retinopathy Dong Ho Park (Kyungpook National University, Korea)
15:20 - 15:40	The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews Geun Joo Choi (Chung-Ang University, Korea)
15:40 - 16:00	Effect of breakfast consumption and meal time regularity on nutrient intake and cardiometabolic health in Korean adults Oh Yoen Kim (Dong-a University, Korea)
16:00 - 16:20	Mesenchymal stem cell-mediated therapy of peripheral artery disease is stimulated by a lamin A-progerin binding inhibitor Jae Ho Kim (Pusan National University, Korea)
16:20 - 16:40	Phosphorylation in novel mitochondrial creatine kinase tyrosine residues render cardioprotection against hypoxia/reoxygenation injury Jin Han (Inje University, Korea)

BREAK: Sep.11(Sat.)
16:40 - 16:50; All

CLOSING CEREMONY: Sep.11(Sat.)
16:50 -; All

Scientific Program